Editorial: Evidence for Assessing Drug Safety and Drug Use in Older People

Front Pharmacol. 2022 Jun 1:13:941813. doi: 10.3389/fphar.2022.941813. eCollection 2022.

Luciane Cruz Lopes¹, Ria Benko^{2

3

4}, Marcio Galvão Oliveira⁵, Vera Maria Vieira Paniz⁶, Brian Godman^{7

8

9}, Fabiane Raquel Motter¹

¹ Graduate Course in Pharmaceutical Sciences, University of Sorocaba (Uniso), São Paulo, Brazil.
² Institution of Clinical Pharmacy, Faculty of Pharmacy, University of Szeged, Szeged, Hungary.
³ Central Pharmacy, Albert Szent Györgyi Medical Center, University of Szeged, Szeged, Hungary.
⁴ Department of Emergency Medicine, Albert Szent Györgyi Medical Center, University of Szeged, Szeged, Hungary.
⁵ Multidisciplinary Health Institute, Federal University of Bahia, Vitória da Conquista, Brazil.
⁶ Postgraduate Program in Collective Health, University of Vale do Rio dos Sinos (UNISINOS), São Leopoldo, Brazil.
⁷ Strathclyde Institute of Pharmacy and Biomedical Sciences, Faculty of Science, University of Strathclyde, Glasgow, United Kingdom.
⁸ Centre of Medical and Bio Allied Health Sciences Research, Ajman University, Ajman, United Arab Emirates.
⁹ Division of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria, South Africa.

No abstract available

Keywords: adverse drug reactions; deprescribing; drug safety; medication without harm; older patients; potentially inappropriate medications.

Publication types